Hospitals across the United States are facing shortages of intravenous (IV) fluids following a plant shutdown in North Carolina caused by Hurricane Helene. The impact of this shortage has been significant, with facilities across the country having to cancel and postpone elective surgeries to conserve their dwindling supplies. Virginia’s UVA Health University Medical Center, for instance, announced that they would be delaying certain surgeries this week due to the shortage.
The shortage of IV fluid is a direct result of flooding at Baxter International’s plant in western North Carolina, which produces vital IV products used for hydration and kidney dialysis treatments. The breach of a levee at the plant has disrupted production, leading to supply chain issues affecting hospitals in Virginia, Massachusetts, Minnesota, and other states. Baxter provides 60 percent of IV products nationwide, equating to 1.5 million bags, with the restoration of the plant expected to take weeks.
As a response to the shortage, hospitals have been forced to find alternative solutions, such as rescheduling surgeries, conserving fluids, and even offering drinks like Gatorade or water to patients in need of hydration. The American Hospitals Association has sent a letter to President Joe Biden urging for immediate action, including declaring a national emergency and invoking the Defense Production Act to address the crisis.
Healthcare providers are under immense pressure to navigate these supply shortages, with facilities in Virginia, Massachusetts, and Minnesota already taking steps to manage the crisis. The long-term impact of these shortages remains uncertain, raising concerns about patient care in the weeks to come. The Biden administration is being called upon to intervene and address the shortage through regulatory measures to ensure continued access to essential medical supplies.
Baxter International, the company responsible for the disrupted plant, is working to assess the damage and develop a plan to resume production as quickly as possible. Despite the challenges posed by the plant shutdown, efforts are underway to restore operations and mitigate the impact on patients in need of IV fluids. The situation remains fluid, and stakeholders are closely monitoring the developments to ensure a swift resolution to the ongoing healthcare crisis.